Imugene Ltd.

(OTC:IUGNF)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Imugene Ltd specializes is a clinical-stage immuno-oncology company. Its product includes HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being Research, Development, and Commercialisation of oncolytic immunotherapies.

Contact Information

Website: www.imugene.com
Main Phone: +61 398245254
Address: 37 Bligh Street
Address 2: Suite 1006, Level 10
State: NSW
City / Town: Sydney
Country: AU
Postal Code: 2000

Issuer Information

Exchange: OTO

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A